Search Tag: Thermo Fisher Scientific

ICU Management

How-to-overcome-antibiotic-overuse-in-covid-19-patients

2021 24 Mar

Speakers Valerie Vaughn Director of Hospital Medicine Research in the Division of General Internal Medicine University of Utah, Salt Lake City, USA Neil Powell Consultant Antimicrobial Pharmacist Royal Cornwall Hospitals NHS Trust, Truro, UK Find Thermo Fisher Scientific on Social Media   Read more

ICU Management

Thermo-fisher-scientific-to-acquire-point-of-care-molecular-diagnostics-provider-mesa-biotech

2021 19 Jan

Thermo Fisher Scientific Inc . (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately  $450 million  in cash. Under the terms of the agreement,  Thermo Fisher  will pay up to an additional  $100 million...Read more

ICU Management

Thermo-fisher-scientific-s-biomarker-b-r-a-h-m-s-copeptin-now-in-the-2015-guidelines-of-the-esc

2015 27 Oct

New diagnostic pathway allows instant rule out of Acute Myocardial Infarction (AMI) with a combination of copeptin and troponin The recently released guidelines by the European Society of Cardiology (ESC) suggest that using measurements of copeptin level together with troponin level is the only new diagnostic pathway that allows an instant and...Read more

ICU Management

Thermo-fisher-scientific-unveils-new-solutions-to-advance-the-use-of-clinical-testing

2015 27 Jul

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has introduced new instruments and assays to expand the use of clinical testing, enhance laboratory productivity and ultimately improve patient outcomes. The new solutions were unveiled at the  2015 AACC Annual Meeting and Clinical Lab Expo , Booth 3135, being held at the...Read more

ICU Management

Thermo-fisher-siemens-renew-partnership-for-sepsis-diagnosis-using-b-r-a-h-m-s-pct-biomarker

2013 06 Sep

Hospital laboratories outside the U.S. can benefit from a continued availability of the B·R·A·H·M·S PCT™ assay on ADVIA Centaur® systems, allowing them to diagnose sepsis early and safely. Thermo Fisher and Siemens Healthcare Diagnostics renew their non-exclusive, long-term, royalty-bearing agreement for the use of...Read more